Edward T. Kang

• Tried a two-week federal jury trial for a leading health insurance company against a group of commercial drug testing laboratories and obtained a complete verdict in client’s favor.
• Defended a leading lender of home equity conversion mortgages in a lawsuit filed by the Department of Justice (DOJ) for alleged violations of the False Claims Act and, after a significant win at the summary judgment phase, obtained a favorable settlement on the client’s behalf.
• National counsel for a leading health insurance company in complex commercial litigation and arbitration matters across the country.
• Defended a Korean precious metals refining company in a $190 million fraud case with favorable results for the client.
• Conducted numerous internal investigations, including anticorruption and sanctions investigations, for Korean conglomerates.
• Defended an Australian power company, resulting in dismissal and avoidance of a default judgment that awarded relief equivalent to $200 million.
• Counsel for individuals and corporations in numerous investigations conducted by the DOJ and U.S. Attorney’s Offices involving allegations related to bribery, health care fraud, wire fraud, false statements, and tax evasion.
• Conducted numerous internal investigations on matters related to the Foreign Corrupt Practices Act (FCPA), Federal Food, Drug, and Cosmetic Act, and antitrust for Fortune 500 companies across a wide range of industries, including aerospace and defense, health care, life sciences, financial services, automotive, information technology, and insurance.
• Served as counsel for a bipartisan coalition of 77 former state attorneys general as amici curiae in former Virginia Governor Robert McDonnell’s successful petition to the U.S. Supreme Court in a landmark ruling limiting the scope of federal bribery laws. McDonnell v. U.S., 136 S.Ct. 2355 (2016).
• Counsel for pharmaceutical companies in a state False Claims Act lawsuit filed by a state attorney general relating to alleged misrepresentations regarding FDA approvals.

Edward (Ted) Kang is the partner-in-charge of the Alston & Bird’s D.C. office and D.C. office leader of the White Collar, Government & Internal Investigations Team. His practice focuses on white collar defense and regulatory compliance, as well as complex commercial litigation in the health care and financial services industries.

Ted represents companies and individuals under investigation by the Department of Justice (DOJ), Securities and Exchange Commission, and other federal and state enforcement agencies. He counsels and conducts internal investigations for clients in an array of industries. Ted has litigated dozens of complex litigation matters across the country and routinely represents clients in federal and state court, arbitration and regulatory proceedings, and mediations. He is an accomplished courtroom lawyer and has tried 13 jury trials to verdict and argued a dozen cases before federal circuit courts.

Ted served for eight years as a federal prosecutor in the DOJ Criminal Division and at the U.S. Attorney’s Office for the District of Connecticut, where he prosecuted some of the department’s most high-profile fraud and public corruption cases. He is Chambers-USA-ranked in White Collar & Government Investigations and was a recipient of the U.S. Attorney General’s Award for Distinguished Service.

律師資格

• 哥倫比亞特區
• 紐約

學歷

• Harvard University (法學博士, 2001)
• Yale University (學士學位, 1998)

Memberships